Cost-effectiveness of HPV vaccination for adults through age 45 years in the United States: Estimates from a simplified transmission model
Harrell W. Chesson, Elissa Meites, Donatus U. Ekwueme, Mona Saraiya, Lauri E. Markowitz
Topics & Concepts
VaccinationMedicineYoung adultTransmission (telecommunications)DemographyAge groupsIncidence (geometry)Quality-adjusted life yearPediatricsHuman papillomavirusCost effectivenessGerontologyImmunologyInternal medicineOpticsPhysicsEngineeringSociologyElectrical engineeringRisk analysis (engineering)Cervical Cancer and HPV ResearchVaccine Coverage and HesitancyHead and Neck Cancer Studies